Novagold (NG) director receives 36,600 stock options vesting through 2029

Rhea-AI Filing Summary

Novagold Resources Inc. director Elaine J. Dorward-King received a grant of stock options on 02/02/2026. She was awarded 36,600 stock options with an exercise price of $8.73 per common share, expiring on 02/01/2031. Following this grant, she beneficially owns 36,600 derivative securities directly. The options vest in three equal installments, with one-third vesting on 02/02/2027, one-third on 02/02/2028, and the final third on 02/02/2029, aligning the award with multi-year service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dorward-King Elaine J

(Last) (First) (Middle)

C/O NOVAGOLD RESOURCES INC.

201 SOUTH MAIN STREET, SUITE 400

(Street)

SALT LAKE CITY UT 84111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NOVAGOLD RESOURCES INC [ NG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$8.73	02/02/2026		A		36,600		(1)	02/01/2031	Common Shares	36,600	$0	36,600	D

Explanation of Responses:

1. The options vest as follows: 1/3 on 02/02/2027; 1/3 on 02/02/2028; and 1/3 on 02/02/2029.

Remarks:

	Elaine J. Dorward-King	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Novagold Resources (NG) director Elaine Dorward-King report on this Form 4?

Elaine Dorward-King reported receiving a stock option grant. On 02/02/2026, she was awarded 36,600 stock options for Novagold common shares at an exercise price of $8.73 per share, all held directly after the transaction.

How many Novagold (NG) stock options were granted to Elaine Dorward-King and at what price?

Elaine Dorward-King was granted 36,600 stock options at $8.73 per share. These options give her the right to buy 36,600 Novagold common shares at that fixed exercise price if and when they vest and are exercised.

What is the vesting schedule for Elaine Dorward-King’s Novagold (NG) stock options?

The options vest in three equal annual installments. One-third of the 36,600 options vests on 02/02/2027, another third on 02/02/2028, and the final third on 02/02/2029, creating a multi-year incentive structure.

When do Elaine Dorward-King’s Novagold (NG) stock options expire?

The stock options expire on 02/01/2031. This expiration date sets the final day by which any vested portion of the 36,600 options can be exercised at the $8.73 per share exercise price.

How many Novagold (NG) derivative securities does Elaine Dorward-King own after this transaction?

After the grant, she beneficially owns 36,600 derivative securities. These consist of stock options held directly, representing rights to acquire an equal number of Novagold common shares under the reported award.

What role does Elaine Dorward-King hold at Novagold Resources (NG) in this filing?

Elaine Dorward-King is identified as a director of Novagold Resources Inc. The Form 4 indicates her relationship as a director, with the reported transaction reflecting an option grant associated with that board role.